1)国立がんセンターがん対策情報センター―人口動態統計によるがん死亡データ(1958-2004年):http://ganjoho.ncc.go.jp/professional/statistics/statistics.html
2)地域がん登録全国推計によるがん罹患データ(1975-2000年):http://ganjoho.ncc.go.jp/professional/statistics/statistics.html
3)Marugame T, kamo K, katanoda K, et al(The Japan Cancer Surveillance Research Group):Cancer incidence and incidence rates in Japan in 2000:Estimates based on data from 11 Population-based cancer registries. Jpn J Clin Oncol 36:668-675, 2006
4)Parkin DM, Whelan SL, Ferlay J, et al(eds):Cancer incidence in five continents, vol.Ⅷ. IARC Scientific Publication No.155. International Agency for Research on Cancer, Lyon, 2002
5)Jemal A, Clegg LX, Ward E, et al:Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101:3-27, 2004
6)横山 正,斎藤晋介,武藤徹一郎:大腸がんの症状.からだの科学 199:39-41,1998
7)Glade MJ:Food, nutrition and the prevention of cancer:A global prespective. World Cancer Research Fund/American Institute for Cancer Research, 1997. Nutrition 15:523-526, 1999
8)玉腰浩司,徳留信寛,栗木清典,他:大腸がんの疫学と予防.癌と化療 28:147-150,2001
Ohigashi H, Osawa T, Terao J, et al(eds);Food Factors for Cancer Prevention. Springer-Verlag, 1997, pp509-512
10)Graham DJ, Campen D, Hui R, et al:Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs:nested case-control study. Lancet 365:475-481, 2005
11)Bresalier RS, Sandler RS, Quan H, et al:Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352:1092-1102, 2005